Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Nadejda Vintonenko"'
Autor:
Mohamed Abdelkarim, Nadejda Vintonenko, Anna Starzec, Aniela Robles, Julie Aubert, Marie-Laure Martin, Samia Mourah, Marie-Pierre Podgorniak, Sylvie Rodrigues-Ferreira, Clara Nahmias, Pierre-Olivier Couraud, Christelle Doliger, Odile Sainte-Catherine, Nicole Peyri, Lei Chen, Jérémie Mariau, Monique Etienne, Gerard-Yves Perret, Michel Crepin, Jean-Luc Poyet, Abdel-Majid Khatib, Mélanie Di Benedetto
Publikováno v:
PLoS ONE, Vol 6, Iss 8, p e23334 (2011)
INTRODUCTION: The poor efficacy of various anti-cancer treatments against metastatic cells has focused attention on the role of tumor microenvironment in cancer progression. To understand the contribution of the extracellular matrix (ECM) environment
Externí odkaz:
https://doaj.org/article/bf19b55f1bfd4906addabfd515120808
Autor:
Mohamed Abdelkarim, Erwann Guenin, Odile Sainte-Catherine, Nadejda Vintonenko, Nicole Peyri, Gerard Yves Perret, Michel Crepin, Abdel-Majid Khatib, Marc Lecouvey, Mélanie Di Benedetto
Publikováno v:
PLoS ONE, Vol 4, Iss 3, p e4685 (2009)
BACKGROUND: Although there was growing evidence in the potential use of Bisphosphonates (BPs) in cancer therapy, their strong osseous affinities that contrast their poor soft tissue uptake limited their use. Here, we developed a new strategy to overc
Externí odkaz:
https://doaj.org/article/3b593742a6f2449fa9ac9584e68396f4
Autor:
Maryline Vo, Alexandra Langlais, Jean-François Seitz, Christine Delpeut, Etienne Bardet, Khe Hoang Xuan, Bénédicte Votan, Claire Mathiot, Denis Moro-Sibilot, Jean Michon, Corinne Haioun, Gilles Salles, Christophe Louvet, Franck Morin, Claire Dubois, Eric Pujade-Lauraine, Nadejda Vintonenko, Philippe Casassus, Pascal Deschaseaux, Bernard Milleron, Cécile Girault
Publikováno v:
Bulletin du Cancer. 104:652-661
Resume Introduction Le Plan Cancer 2014–2019 insiste sur l’importance de la collaboration entre tous les acteurs de la recherche clinique dans la lutte contre le cancer, dont les intergroupes et groupes cooperateurs. Cette enquete avait pour obje
Autor:
Claire, Dubois, Franck, Morin, Denis, Moro-Sibilot, Alexandra, Langlais, Jean-François, Seitz, Cécile, Girault, Gilles, Salles, Corinne, Haioun, Pascal, Deschaseaux, Philippe, Casassus, Claire, Mathiot, Éric, Pujade-Lauraine, Bénédicte, Votan, Christophe, Louvet, Christine, Delpeut, Étienne, Bardet, Nadejda, Vintonenko, Khê, Hoang Xuan, Maryline, Vo, Jean, Michon, Bernard, Milleron
Publikováno v:
Bulletin du cancer. 104(7-8)
The French Cancer Plan 2014-2019 stresses the importance of strengthening collaboration between all stakeholders involved in the fight against cancer, including cancer cooperative groups and intergroups. This survey aimed to describe the basics chara
Autor:
Cécile Michel, C. Mertens, H. Le Caer, Caroline Even, Nadejda Vintonenko, Cécile Ortholan, Sophie Renard-Oldrini, X. Sun, D. Vansteene, Jérôme Fayette, A. Auperin, L. Mayache-Badis, Lionel Geoffrois, Joël Guigay, Dominique Schwob, J. H. Bourhis, Y. Pointreau
Publikováno v:
Radiotherapy and Oncology. 122:70-71
Autor:
Nadejda Vintonenko, Rosette Lidereau, Ivan Bièche, Martine Perrot-Applanat, Gérard Y Perret, Hélène Buteau-Lozano, Irma Pelaez-Garavito, Aurore Toullec
Publikováno v:
Cell Adhesion & Migration. 5:332-343
The existence of multiple VEGF-A isoforms raised the possibility that they may have distinct functions in tumor growth. We have previously published that VEGF189 and VEGF165 contribute to breast cancer progression and angiogenesis, but VEGF165 induce
Autor:
J. Delaye, Caroline Even, Esma Saada-Bouzid, N. Baste Rotllan, Amaury Daste, Florence Huguet, I. Jallut, Joël Guigay, J. Fayette, Sylvie Zanetta, M-C. Kaminsky-Forrett, G. Lefebvre, J.-P. Delord, M. Texier, D. Cupissol, Anne Auperin, Christian Borel, J. H. Bourhis, A. Prevost, Nadejda Vintonenko
Publikováno v:
Annals of Oncology. 29:viii380
Autor:
Mohamed Abdelkarim, Michel Crépin, Marc Lecouvey, Nadejda Vintonenko, Jean-Philippe Jais, Gérard-Yves Perret, Nadim Kassis, Mélanie Di Benedetto
Publikováno v:
Molecular pharmacology. 82(3)
Statins and bisphosphonates are two distinct classes of isoprenoid pathway inhibitors targeting downstream enzyme to HMG-CoA reductase (upstream enzyme) and farnesyl-pyrophosphate synthase, respectively. Here, we studied fluvastatin (Fluva) and zoled
Autor:
Clara Nahmias, Marie-Pierre Podgorniak, Sylvie Rodrigues-Ferreira, Abdel-Majid Khatib, Nicole Peyri, Julie Aubert, Nadejda Vintonenko, Michel Crépin, Lei Chen, Anna Starzec, Mélanie Di Benedetto, Pierre-Olivier Couraud, Christelle Doliger, Odile Sainte-Catherine, Gérard-Yves Perret, Jean-Luc Poyet, Aniela Robles, Jérémie Mariau, Monique Etienne, Marie-Laure Martin, Mohamed Abdelkarim, Samia Mourah
Publikováno v:
PLoS ONE
PLoS ONE, Public Library of Science, 2011, 6 (8), pp.e23334. ⟨10.1371/journal.pone.0023334⟩
PLoS ONE, Vol 6, Iss 8, p e23334 (2011)
Plos One 8 (6), 1-13. (2011)
PLoS ONE, Public Library of Science, 2011, 6 (8), pp.e23334. ⟨10.1371/journal.pone.0023334⟩
PLoS ONE, Vol 6, Iss 8, p e23334 (2011)
Plos One 8 (6), 1-13. (2011)
1 - Article; Introduction: The poor efficacy of various anti-cancer treatments against metastatic cells has focused attention on the role of tumor microenvironment in cancer progression. To understand the contribution of the extracellular matrix (ECM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::357a24c048e6a1a4250c97193a273a37
https://hal.archives-ouvertes.fr/hal-00705949/file/journal.pone.0023334_1.pdf
https://hal.archives-ouvertes.fr/hal-00705949/file/journal.pone.0023334_1.pdf
Publikováno v:
Journal of Clinical Oncology. 33:TPS6087-TPS6087
6002Background: After promising results from the GORTEC TPEx phase II trial, the role of taxane instead of 5FU in 1st-line R/M HNSCC chemotherapy (CT) remained to be confirmed by comparing TPEx to ...